Literature DB >> 16003053

Community-acquired bacteria frequently detected by means of quantitative polymerase chain reaction in nosocomial early-onset ventilator-associated pneumonia.

Petra Apfalter1, Brigitte Stoiser, Wolfgang Barousch, Marion Nehr, Ludwig Kramer, Heinz Burgmann.   

Abstract

OBJECTIVE: To test whether real-time polymerase chain reaction allows for rapid quantitative detection of Streptococcus pneumoniae, Chlamydia pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila in bronchoalveolar lavage fluids and to determine the prevalence of these pathogens in nosocomial ventilator-associated pneumonia.
DESIGN: Prospective epidemiologic study applying a new molecular biology-based diagnostic tool during a 27-month period.
SETTING: Three medical intensive care units of a tertiary care university hospital. PATIENTS: One hundred patients suffering from nosocomial ventilator-associated pneumonia, hospitalized for > or =14 days, intubated for reasons other than pneumonia, and mechanically ventilated for >48 hrs.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: S. pneumoniae, M. pneumoniae, and C. pneumoniae were detected in bronchoalveolar lavage fluids of 100 patients in 20 (20%), three (3%), and two (2%) cases, respectively. There of 17 (71%) revealed no growth or no significant growth by conventional culture. In one patient, S. pneumoniae and M. pneumoniae were detected simultaneously. Corresponding colony-forming units/mL were partly up to 10 CFU/mL with Gram stainings showing signs of acute inflammation in 80%. A significant temporary correlation between the number of days on ventilator, development of nosocomial pneumonia, and the frequency of detection of these pathogens was found for day 4.
CONCLUSIONS: S. pneumoniae, M. pneumoniae, and C. pneumoniae should be considered as causative agents in critically ill patients who develop early-onset nosocomial ventilator-associated pneumonia. Thus, empirical antimicrobial regimens should cover S. pneumoniae, Chlamydia, and Mycoplasma alike. Quantitative polymerase chain reaction is a fast diagnostic tool allowing for detection of these bacteria within 3 hrs in pretreated patients.

Entities:  

Mesh:

Year:  2005        PMID: 16003053     DOI: 10.1097/01.ccm.0000169879.97129.7b

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  8 in total

1.  M. pneumoniae and C. pneumoniae are no relevant pathogens in critically ill patients with hospital-acquired respiratory tract infections.

Authors:  Stefan Hagel; Svenja Schmitt; Miriam Kesselmeier; Michael Baier; Tobias Welte; Santiago Ewig; Mathias W Pletz
Journal:  Infection       Date:  2019-01-28       Impact factor: 3.553

2.  Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.

Authors:  S V Yakovlev; L S Stratchounski; G L Woods; B Adeyi; K A McCarroll; J A Ginanni; I R Friedland; C A Wood; M J DiNubile
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-10       Impact factor: 3.267

3.  Novel toxin assays implicate Mycoplasma pneumoniae in prolonged ventilator course and hypoxemia.

Authors:  Mark T Muir; Stephen M Cohn; Christopher Louden; Thirumalai R Kannan; Joel B Baseman
Journal:  Chest       Date:  2010-09-30       Impact factor: 9.410

4.  Rapid identification of penicillin and macrolide resistance genes and simultaneous quantification of Streptococcus pneumoniae in purulent sputum samples by use of a novel real-time multiplex PCR assay.

Authors:  Kazuko Y Fukushima; Katsunori Yanagihara; Yoichi Hirakata; Kazuyuki Sugahara; Yoshitomo Morinaga; Shigeru Kohno; Shimeru Kamihira
Journal:  J Clin Microbiol       Date:  2008-05-07       Impact factor: 5.948

5.  Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA.

Authors:  Maria da Gloria S Carvalho; Maria Lucia Tondella; Karen McCaustland; Luciana Weidlich; Lesley McGee; Leonard W Mayer; Arnold Steigerwalt; Melissa Whaley; Richard R Facklam; Barry Fields; George Carlone; Edwin W Ades; Ron Dagan; Jacquelyn S Sampson
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

6.  [Mycoplasma pneumoniae infections: retrospective study in Basse-Normandie, 1997-2005. Epidemiology--diagnostic utility of serology and PCR for a rapid diagnostic].

Authors:  J Petitjean-Lecherbonnier; A Vabret; S Gouarin; J Dina; L Legrand; F Freymuth
Journal:  Pathol Biol (Paris)       Date:  2006-10-06

7.  Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia.

Authors:  Naomi J Gadsby; Clark D Russell; Martin P McHugh; Harriet Mark; Andrew Conway Morris; Ian F Laurenson; Adam T Hill; Kate E Templeton
Journal:  Clin Infect Dis       Date:  2016-01-07       Impact factor: 9.079

8.  A study of community-acquired Mycoplasma pneumoniae in Yantai, China.

Authors:  Hong-Xia Yu; Mao-Mao Zhao; Zeng-Hui Pu; Yuan-Rong Ju; Yan Liu
Journal:  Colomb Med (Cali)       Date:  2018-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.